These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1415 related articles for article (PubMed ID: 34374761)

  • 1. Severe Acute Respiratory Syndrome Coronavirus 2 Viremia Is Associated With Coronavirus Disease 2019 Severity and Predicts Clinical Outcomes.
    Jacobs JL; Bain W; Naqvi A; Staines B; Castanha PMS; Yang H; Boltz VF; Barratt-Boyes S; Marques ETA; Mitchell SL; Methé B; Olonisakin TF; Haidar G; Burke TW; Petzold E; Denny T; Woods CW; McVerry BJ; Lee JS; Watkins SC; St Croix CM; Morris A; Kearney MF; Ladinsky MS; Bjorkman PJ; Kitsios GD; Mellors JW
    Clin Infect Dis; 2022 May; 74(9):1525-1533. PubMed ID: 34374761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma SARS-CoV-2 RNA Levels as a Biomarker of Lower Respiratory Tract SARS-CoV-2 Infection in Critically Ill Patients With COVID-19.
    Jacobs JL; Naqvi A; Shah FA; Boltz VF; Kearney MF; McVerry BJ; Ray P; Schaefer C; Fitzpatrick M; Methé B; Lee JS; Morris A; Mellors JW; Kitsios GD; Bain W
    J Infect Dis; 2022 Dec; 226(12):2089-2094. PubMed ID: 35511031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease.
    Hogan CA; Stevens BA; Sahoo MK; Huang C; Garamani N; Gombar S; Yamamoto F; Murugesan K; Kurzer J; Zehnder J; Pinsky BA
    Clin Infect Dis; 2021 May; 72(9):e291-e295. PubMed ID: 32965474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of transfusion-transmitted infection with severe acute respiratory syndrome coronavirus 2 from blood donors in Japan.
    Shinohara N; Ito M; Kai K; Kamo N; Owada T; Sobata R; Yamagishi N; Takahashi H; Ikeda Y; Sawai H; Furuta RA; Matsubayashi K; Hino I; Goto N; Satake M
    Transfusion; 2024 Jan; 64(1):116-123. PubMed ID: 38088084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Kinetics of SARS-CoV-2 Antibody Development Is Associated with Clearance of RNAemia.
    Wang C; Li Y; Kaplonek P; Gentili M; Fischinger S; Bowman KA; Sade-Feldman M; Kays KR; Regan J; Flynn JP; Goldberg MB; Hacohen N; Filbin MR; Lauffenburger DA; Alter G; Li JZ
    mBio; 2022 Aug; 13(4):e0157722. PubMed ID: 35762593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019.
    Tang K; Wu L; Luo Y; Gong B
    J Med Virol; 2021 May; 93(5):3165-3175. PubMed ID: 33590923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care.
    Gutmann C; Takov K; Burnap SA; Singh B; Ali H; Theofilatos K; Reed E; Hasman M; Nabeebaccus A; Fish M; McPhail MJ; O'Gallagher K; Schmidt LE; Cassel C; Rienks M; Yin X; Auzinger G; Napoli S; Mujib SF; Trovato F; Sanderson B; Merrick B; Niazi U; Saqi M; Dimitrakopoulou K; Fernández-Leiro R; Braun S; Kronstein-Wiedemann R; Doores KJ; Edgeworth JD; Shah AM; Bornstein SR; Tonn T; Hayday AC; Giacca M; Shankar-Hari M; Mayr M
    Nat Commun; 2021 Jun; 12(1):3406. PubMed ID: 34099652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.
    Kawasuji H; Morinaga Y; Tani H; Yoshida Y; Takegoshi Y; Kaneda M; Murai Y; Kimoto K; Ueno A; Miyajima Y; Fukui Y; Kimura M; Yamada H; Sakamaki I; Yamamoto Y
    J Med Virol; 2022 Jan; 94(1):147-153. PubMed ID: 34411312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Acute Respiratory Syndrome Coronavirus 2 RNAemia and Clinical Outcomes in Children With Coronavirus Disease 2019.
    Mertz C; Glowinski R; Cohen SH; Mertz S; Ye F; Hall MW; Peeples ME; King T; Wang H; Leber AL; Sanchez PJ; Ramilo O; Mejias A
    J Infect Dis; 2022 Jan; 225(2):208-213. PubMed ID: 34618885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.
    Bermejo-Martin JF; González-Rivera M; Almansa R; Micheloud D; Tedim AP; Domínguez-Gil M; Resino S; Martín-Fernández M; Ryan Murua P; Pérez-García F; Tamayo L; Lopez-Izquierdo R; Bustamante E; Aldecoa C; Gómez JM; Rico-Feijoo J; Orduña A; Méndez R; Fernández Natal I; Megías G; González-Estecha M; Carriedo D; Doncel C; Jorge N; Ortega A; de la Fuente A; Del Campo F; Fernández-Ratero JA; Trapiello W; González-Jiménez P; Ruiz G; Kelvin AA; Ostadgavahi AT; Oneizat R; Ruiz LM; Miguéns I; Gargallo E; Muñoz I; Pelegrin S; Martín S; García Olivares P; Cedeño JA; Ruiz Albi T; Puertas C; Berezo JÁ; Renedo G; Herrán R; Bustamante-Munguira J; Enríquez P; Cicuendez R; Blanco J; Abadia J; Gómez Barquero J; Mamolar N; Blanca-López N; Valdivia LJ; Fernández Caso B; Mantecón MÁ; Motos A; Fernandez-Barat L; Ferrer R; Barbé F; Torres A; Menéndez R; Eiros JM; Kelvin DJ
    Crit Care; 2020 Dec; 24(1):691. PubMed ID: 33317616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value.
    Veyer D; Kernéis S; Poulet G; Wack M; Robillard N; Taly V; L'Honneur AS; Rozenberg F; Laurent-Puig P; Bélec L; Hadjadj J; Terrier B; Péré H
    Clin Infect Dis; 2021 Nov; 73(9):e2890-e2897. PubMed ID: 32803231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 RNAemia and Disease Severity in COVID-19 Patients.
    Lawrence Panchali MJ; Kim CM; Seo JW; Kim DY; Yun NR; Kim DM
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients.
    Eberhardt KA; Meyer-Schwickerath C; Heger E; Knops E; Lehmann C; Rybniker J; Schommers P; Eichenauer DA; Kurth F; Ramharter M; Kaiser R; Holtick U; Klein F; Jung N; Di Cristanziano V
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32962125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of viremia on organ failure, biomarkers and mortality in a Swedish cohort of critically ill COVID-19 patients.
    Järhult JD; Hultström M; Bergqvist A; Frithiof R; Lipcsey M
    Sci Rep; 2021 Mar; 11(1):7163. PubMed ID: 33785784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevant SARS-CoV-2 viremia is associated with COVID-19 severity: Prospective cohort study and validation cohort.
    Cardeñoso Domingo L; Roy Vallejo E; Zurita Cruz ND; Chicot Llano M; Ávalos Pérez-Urria E; Barrios A; Hernando Santos J; Ortiz J; Rodríguez García SC; Martín Ramírez A; Ciudad Sañudo M; Marcos C; García Castillo E; Fontán García-Rodrigo L; González B; Méndez R; Iturrate I; Sanz García A; Villa A; Sánchez Azofra A; Quicios B; Arribas D; Álvarez Rodríguez J; Patiño P; Trigueros M; Uriarte M; Triguero Martínez A; Arévalo C; Galván Román JM; García-Vicuña R; Ancochea J; Soriano JB; Canabal A; Muñoz Calleja C; De la Cámara R; Suarez Fernández C; González Álvaro I; Rodríguez-Serrano DA;
    J Med Virol; 2022 Nov; 94(11):5260-5270. PubMed ID: 35811284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of convalescent plasma therapy in severe COVID-19 patients with persistent SARS-CoV-2 viremia.
    Camou F; Tinevez C; Beguet-Yachine M; Bellecave P; Ratiarison D; Tumiotto C; Lafarge X; Guisset O; Mourissoux G; Lafon ME; Bonnet F; Issa N
    J Med Virol; 2021 Sep; 93(9):5594-5598. PubMed ID: 33942327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining predictive markers for severe COVID-19: Torquetenovirus DNA load and SARS-CoV-2 RNAemia.
    Solis M; Gallais F; Garnier-Kepka S; Lefebvre N; Benotmane I; Ludes PO; Castelain V; Meziani F; Caillard S; Collange O; Fafi-Kremer S
    J Clin Virol; 2022 Mar; 148():105120. PubMed ID: 35227970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Acute Respiratory Syndrome Coronavirus 2 RNA in Plasma Is Associated With Intensive Care Unit Admission and Mortality in Patients Hospitalized With Coronavirus Disease 2019.
    Prebensen C; Myhre PL; Jonassen C; Rangberg A; Blomfeldt A; Svensson M; Omland T; Berdal JE
    Clin Infect Dis; 2021 Aug; 73(3):e799-e802. PubMed ID: 32888003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study.
    Colagrossi L; Antonello M; Renica S; Merli M; Matarazzo E; Travi G; Vecchi M; Colombo J; Muscatello A; Grasselli G; Molteni SN; Scaravilli V; Cattaneo E; Fanti D; Vismara C; Bandera A; Gori A; Puoti M; Cento V; Alteri C; Perno CF
    BMC Infect Dis; 2021 Feb; 21(1):184. PubMed ID: 33596855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.
    Wu F; Liu M; Wang A; Lu L; Wang Q; Gu C; Chen J; Wu Y; Xia S; Ling Y; Zhang Y; Xun J; Zhang R; Xie Y; Jiang S; Zhu T; Lu H; Wen Y; Huang J
    JAMA Intern Med; 2020 Oct; 180(10):1356-1362. PubMed ID: 32808970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.